Gemopatrilat
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | BMS-189921 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C19H26N2O4S |
| Molar mass | 378.49 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Gemopatrilat (INN) is an experimental drug that was never marketed. It acts as a vasopeptidase inhibitor. It inhibits both angiotensin-converting enzyme (ACE) and neutral endopeptidase (neprilysin).
|
ACE inhibitors ("-pril") |
|
|---|---|
|
AIIRAs ("-sartan") |
|
|
Renin inhibitors ("-kiren") |
|
| Dual ACE/NEP inhibitors | |
| Neprilysin inhibitors | |
| |